Detection of immune markers in peripheral blood of patients with sepsis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047060

Enrollment

Unknown

Registered

2021-06-07

Start date

2021-06-30

Completion date

Unknown

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

sepsis group :Nil

common infection group:Nil

healthy control group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Adult sepsis patients who meet the diagnostic criteria of septis-3; 2. Adult patients with common infection (without infection-related organ failure) ; 3. Adult healthy control.

Exclusion criteria

Exclusion criteria: 1. The subjects who have any ongoing autoimmune diseases or have a history of autoimmune diseases; 2. Tumor patients (including solid tumors and blood system tumors); 3. Patients who used hormones or immunosuppressants within 14 days of enrollment; 4. Human immunodeficiency virus (HIV) infection, tuberculosis mycobacteria infection, hepatitis B virus infected patients; 5. Pregnant women and other special groups.

Design outcomes

Primary

Measure	Time frame
RNA sequencing;	—

Countries

China

Contacts

Public ContactKang Yan

West China Hospital of Sichuan University

Kangyan_5626@hotmail.com+86 18980601566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026